Clinical Trial Details


Research Study Summary

A multicenter, randomized, double-blind study to evaluate the efficacy, safety and tolerability of an oral Aripiprazole-Escitalopram combination therapy in patients with Major Depressive Disorder.


This study is being done to find out the potential benefits and safety of taking two different study drugs at the same time. The study drugs are called Abilify(aripiprazole) and Lexapro(Escitalopram).

Please contact Alexian Brothers for more information on participation.

To Learn more

CW ID: 176874
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Alexian Brothers Hospital Network
1786 Moon Lake Boulevard, Suite 200
Hoffman Estates, IL 60169
Phone: 847-230-3599

View Map

Research Center Information:

Alexian Brothers Hospital Network

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.